| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 11 Feb 25 | ORMP Oramed Pharmaceuticals | Common Stock | Grant | Acquire A | No | No | 0 | 33,334 | 0.00 | 833,167 |
| 11 Feb 25 | ORMP Oramed Pharmaceuticals | Common Stock | Grant | Acquire A | No | No | 0 | 48,500 | 0.00 | 799,833 |
| 11 Feb 25 | ORMP Oramed Pharmaceuticals | Common Stock | Grant | Acquire A | No | No | 0 | 45,000 | 0.00 | 751,333 |
| 2 Jan 25 | ORMP Oramed Pharmaceuticals | Common Stock | Grant | Acquire A | No | No | 0 | 194,500 | 0.00 | 706,333 |
| 7 Nov 24 | ORMP Oramed Pharmaceuticals | Common Stock | Grant | Acquire A | No | No | 0 | 30,000 | 0.00 | 511,833 |
| 4 Jan 24 | ORMP Oramed Pharmaceuticals | Common Stock | Grant | Acquire A | No | No | 0 | 180,500 | 0.00 | 481,833 |
